Back to search
FDAFDA · Food and drugs·Recall number D-107-2013

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

Published January 9, 2013 · Recall initiated: December 4, 2012

Summary

FDA records drug Class II recall D-107-2013, published January 9, 2013 and initiated December 4, 2012. Recalling firm: Abbott Laboratories; Status: Terminated; Reported quantity: 28, 524 bottles; Lot: LOT # 18262A8 Exp. 09/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if SYNTHROID has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SYNTHROID
Manufacturer
Abbott Laboratories
Distributor
US Nationwide and Puerto Rico
UPC
0300747149902
Lot
LOT # 18262A8 Exp. 09/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A. recalled?

Yes. FDA published recall D-107-2013 on January 9, 2013. Reported hazard: Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SYNTHROID. UPC: 0300747149902.